RedHill Biopharma (RDHL) Common Equity (2011 - 2026)
RedHill Biopharma (RDHL) recorded Common Equity of -$1.08 million in the quarter ended Jun 30, 2026, compared with -$4.41 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Common Equity (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, RedHill Biopharma reported Common Equity of $4.27 million.
- Annual Common Equity has a five-year compound annual growth rate of -21.0% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Common Equity came in at -$4.68 million in the year ended Dec 31, 2024, $2.07 million in the year ended Dec 31, 2023, -$48.4 million in the year ended Dec 31, 2022 and $8.88 million in the year ended Dec 31, 2021 (-36.0%).
- Quarterly Common Equity has ranged from -$48.4 million in the quarter ended Dec 31, 2022 to $11.55 million in the quarter ended Sep 30, 2021 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - | -1.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.08 Mn |
| Dec 31, 2025 | 4.27 Mn |
| Jun 30, 2025 | -4.41 Mn |
| Dec 31, 2024 | -4.68 Mn |
| Jun 30, 2024 | 61,000.00 |
| Dec 31, 2023 | 2.07 Mn |
| Jun 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | -48.40 Mn |
| Sep 30, 2022 | -46.03 Mn |
| Jun 30, 2022 | -11.94 Mn |
| Mar 31, 2022 | -8.63 Mn |
| Dec 31, 2021 | 8.88 Mn |
| Sep 30, 2021 | 11.55 Mn |
| Jun 30, 2021 | 29.58 Mn |
| Mar 31, 2021 | 53.04 Mn |
| Dec 31, 2020 | 13.86 Mn |
| Sep 30, 2020 | 28.75 Mn |
| Jun 30, 2020 | 34.59 Mn |
| Mar 31, 2020 | 43.65 Mn |
API Access
RedHill Biopharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();